100 studies found for:
"MECP2 duplication syndrome" OR "Mental Retardation, X-Linked"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Enrolling by invitation |
Genetic Disease Gene Identification
|
||||
| 2 | Unknown † |
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|
||||
| 3 | Completed |
A Study to Test the Possibility of Cross Reaction Induced by the Idursulfase Drug to GSK2788723
|
||||
| 4 | Recruiting |
Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
|
||||
| 5 |
Completed
Has Results |
Stem Cell Transplant for Inborn Errors of Metabolism
|
||||
| 6 | Recruiting |
EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes
|
||||
| 7 | Completed |
Study of the Pathogenesis of Rett Syndrome
|
||||
| 8 | Completed |
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)
|
||||
| 9 | Completed |
Predictors of Caregiver Adaptation to Pervasive Developmental Disorders
|
||||
| 10 | Recruiting |
Genetic and Physical Characteristics of Rett Syndrome
|
||||
| 11 | Completed |
Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease
|
||||
| 12 | Completed |
Creatine Metabolism in Rett Syndrome
|
||||
| 13 | Completed |
Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)
|
||||
| 14 | Recruiting |
Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy
|
||||
| 15 | Recruiting |
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
|
||||
| 16 | Completed |
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
|
||||
| 17 | Recruiting |
The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
|
||||
| 18 | Active, not recruiting |
Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome
|
||||
| 19 | Completed |
Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome
|
||||
| 20 | Active, not recruiting |
An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients
|
† Indicates status has not been verified in more than two years
